Cargando…
Plasma ceramides relate to mild cognitive impairment in middle‐aged men: The Maastricht Study
INTRODUCTION: There is an urgent need for biomarkers identifying individuals at risk of early‐stage cognitive impairment. Using cross‐sectional data from The Maastricht Study, this study included 197 individuals with mild cognitive impairment (MCI) and 200 cognitively unimpaired individuals aged 40...
Autores principales: | van Kruining, Daan, Losen, Mario, Crivelli, Simone M., de Jong, Joost J. A., Jansen, Jacobus F. A., Backes, Walter H., Monereo‐Sánchez, Jennifer, van Boxtel, Martin P. J., Köhler, Sebastian, Linden, David E. J., Schram, Miranda T., Mielke, Michelle M., Martinez‐Martinez, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478166/ https://www.ncbi.nlm.nih.gov/pubmed/37675435 http://dx.doi.org/10.1002/dad2.12459 |
Ejemplares similares
-
The association of prediabetes and type 2 diabetes with hippocampal subfields volume: The Maastricht study
por: Monereo-Sánchez, Jennifer, et al.
Publicado: (2023) -
The association of white matter connectivity with prevalence, incidence and course of depressive symptoms: The Maastricht Study
por: Geraets, Anouk F. J., et al.
Publicado: (2023) -
Associations of the Lifestyle for Brain Health Index With Structural Brain Changes and Cognition: Results From the Maastricht Study
por: Heger, Irene S., et al.
Publicado: (2021) -
The relation of depression with structural brain abnormalities and cognitive functioning: the Maastricht study
por: Geraets, Anouk F. J., et al.
Publicado: (2022) -
CERT(L) reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease
por: Crivelli, Simone M., et al.
Publicado: (2021)